Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Fenaux

Showing results (51-60 of 432) with videos related to

Pageof 44
Sort By:
Leukemia & Lymphoma|April 11, 2003
Primary central nervous system lymphoma in immunocompetent adults: poor results mainly associated with high treatment related toxicitiesStéphane Depil, Valérie Coiteux, Gaëlle Guillerm, et al.
Annals of Hematology|September 11, 2013
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomesAristoteles Giagounidis, Ghulam J Mufti, Pierre Fenaux, et al.
Critical Reviews in Oncology/Hematology|July 12, 2017
Azacitidine in adult patients with acute myeloid leukemiaAndre C Schuh, Hartmut Döhner, Lisa Pleyer, et al.
Leukemia|July 21, 2018
Molecular remission as a therapeutic objective in acute promyelocytic leukemiaLaura Cicconi, Pierre Fenaux, Hagop Kantarjian, et al.
Cancer Genetics and Cytogenetics|April 30, 2005
A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmationVirginie Eclache, Franck Viguie, Claudie Frocrain, et al.
European Journal of Haematology|October 12, 2023
MDS/CMML from resource-limited region: Characteristics and comparison to tertiary reference European centerAnna Sevoyan, Arsène Mekinian, Fatiha Chermat, et al.
Leukemia Research|January 1, 2013
Health-related quality of life outcomes of lenalidomide in transfusion-dependent patients with Low- or Intermediate-1-risk myelodysplastic syndromes with a chromosome 5q deletion: results from a randomized clinical trialDennis A Revicki, Nancy A Brandenburg, Petra Muus, et al.
Haematologica|December 30, 2006
Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular responseBruno Cassinat, Isabelle Guillemot, Cécile Moluçon-Chabrot, et al.
EMBO Reports|January 28, 2025
Mutant p53 regulates a distinct gene set by a mode of genome occupancy that is shared with wild typeRamy Rahmé, Lois Resnick-Silverman, Vincent Anguiano, et al.
Seminars in Thrombosis and Hemostasis|July 1, 2006
Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemiaJean-Jacques Kiladjian, Jean-Didier Rain, Jean-Francois Bernard, et al.
Pageof 44

Showing results (51-60 of 432) with videos related to

Sort By:
Pageof 44
Leukemia & Lymphoma|April 11, 2003
Primary central nervous system lymphoma in immunocompetent adults: poor results mainly associated with high treatment related toxicitiesStéphane Depil, Valérie Coiteux, Gaëlle Guillerm, et al.
Annals of Hematology|September 11, 2013
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomesAristoteles Giagounidis, Ghulam J Mufti, Pierre Fenaux, et al.
Critical Reviews in Oncology/Hematology|July 12, 2017
Azacitidine in adult patients with acute myeloid leukemiaAndre C Schuh, Hartmut Döhner, Lisa Pleyer, et al.
Leukemia|July 21, 2018
Molecular remission as a therapeutic objective in acute promyelocytic leukemiaLaura Cicconi, Pierre Fenaux, Hagop Kantarjian, et al.
Cancer Genetics and Cytogenetics|April 30, 2005
A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmationVirginie Eclache, Franck Viguie, Claudie Frocrain, et al.
European Journal of Haematology|October 12, 2023
MDS/CMML from resource-limited region: Characteristics and comparison to tertiary reference European centerAnna Sevoyan, Arsène Mekinian, Fatiha Chermat, et al.
Leukemia Research|January 1, 2013
Health-related quality of life outcomes of lenalidomide in transfusion-dependent patients with Low- or Intermediate-1-risk myelodysplastic syndromes with a chromosome 5q deletion: results from a randomized clinical trialDennis A Revicki, Nancy A Brandenburg, Petra Muus, et al.
Haematologica|December 30, 2006
Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular responseBruno Cassinat, Isabelle Guillemot, Cécile Moluçon-Chabrot, et al.
EMBO Reports|January 28, 2025
Mutant p53 regulates a distinct gene set by a mode of genome occupancy that is shared with wild typeRamy Rahmé, Lois Resnick-Silverman, Vincent Anguiano, et al.
Seminars in Thrombosis and Hemostasis|July 1, 2006
Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemiaJean-Jacques Kiladjian, Jean-Didier Rain, Jean-Francois Bernard, et al.
Pageof 44